Xuereb Maria, Vella Paul, Damidot Denis, Sammut Charles V, Camilleri Josette
Faculty of Dental Surgery, Department of Restorative Dentistry, University of Malta, Msida, Malta.
EM Douai, LGCgE-GCE, Douai, France.
J Endod. 2015 Jan;41(1):111-24. doi: 10.1016/j.joen.2014.09.015. Epub 2014 Oct 30.
EndoSequence BC Sealer (Brasseler, Savannah, GA) is a premixed tricalcium silicate-based root canal sealer that requires moisture from the root dentin to hydrate. The aim of this study was to investigate the setting of EndoSequence BC Sealer and other sealers in contact with human dentin in a simulated clinical environment.
EndoSequence BC Sealer, MTA Fillapex (Angelus, Londrina, Brazil), Septodont Sealer (Septodont, Saint Maur-des-Fosses, France), and Apexit Plus (Ivoclar, Schaan, Lichtenstein) were assessed. Caries-free lower premolars extracted for orthodontic purposes in patients aged 13-16 years were standardized to a 10-mm root length and were filled with test sealers and set up in a dentin pressure model for 14 days. In addition, set sealers immersed in physiologic solution for 14 days were also assessed. The set materials in solution and materials retrieved from the dentin pressure setup were characterized by scanning electron microscopy and X-ray diffraction analysis. The setting time and radiopacity were assessed using ISO 6876:2002 specifications. Furthermore, mineral ion leaching was evaluated by inductively coupled plasma mass spectrometry.
All the sealers tested exhibited formation of a calcium phosphate phase when in contact with physiologic solution. Septodont Sealer and Apexit Plus did not exhibit the formation of a calcium phosphate phase in the dentin pressure setup. The fluid in the system was enough to allow the setting of EndoSequence BC Sealer, which did not set in a dry environment. All materials leached calcium with the Septodont Sealer, exhibiting double the calcium ion leaching compared with EndoSequence BC Sealer.
Using the dentinal fluid pressure system resulted in an adequate flow of dentinal fluid that allowed EndoSequence BC Sealer to set inside the root canal. Although the sealers tested were tricalcium silicate based, the hydration reaction and bioactivity in the presence of dentinal fluid were different to hydration in vitro. Thus, clinically, material bioactivity cannot be assumed.
EndoSequence BC封闭剂(Brasseler公司,佐治亚州萨凡纳市)是一种预混合的硅酸三钙基根管封闭剂,需要来自牙根牙本质的水分来水化。本研究的目的是在模拟临床环境中研究EndoSequence BC封闭剂和其他封闭剂与人类牙本质接触时的凝固情况。
对EndoSequence BC封闭剂、MTA Fillapex(Angelus公司,巴西隆德里纳市)、Septodont封闭剂(Septodont公司,法国圣莫尔-德富塞)和Apexit Plus(Ivoclar公司,列支敦士登公国沙恩市)进行评估。从13至16岁患者中因正畸目的拔除的无龋下颌前磨牙标准化为10毫米的牙根长度,并用测试封闭剂填充,然后在牙本质压力模型中放置14天。此外,还评估了浸泡在生理溶液中14天的凝固封闭剂。通过扫描电子显微镜和X射线衍射分析对溶液中的凝固材料和从牙本质压力装置中取出的材料进行表征。使用ISO 6876:2002规范评估凝固时间和射线不透性。此外,通过电感耦合等离子体质谱法评估矿物离子的浸出情况。
所有测试的封闭剂在与生理溶液接触时均表现出磷酸钙相的形成。Septodont封闭剂和Apexit Plus在牙本质压力装置中未表现出磷酸钙相的形成。系统中的液体足以使EndoSequence BC封闭剂凝固,而该封闭剂在干燥环境中不会凝固。所有材料都浸出了钙,Septodont封闭剂浸出的钙离子是EndoSequence BC封闭剂的两倍。
使用牙本质液压力系统可使牙本质液充分流动,从而使EndoSequence BC封闭剂在根管内凝固。尽管测试的封闭剂是以硅酸三钙为基础的,但在牙本质液存在下的水化反应和生物活性与体外水化不同。因此,在临床上,不能假定材料的生物活性。